|
T25268 |
Coblopasvir
|
|
Others
|
|
Coblopasvir is a pan-genotypic non-structural protein 5A (NS5A) inhibitor. It can be used to study chronic hepatitis C virus infection. |
|
T9341 |
Bemnifosbuvir
|
AT-511 |
Others
,
HCV Protease
,
SARS-CoV
|
|
Bemnifosbuvir (AT-511) is a novel phosphoramidate prodrug of 2'-fluoro-2'-C-methylguanosine-5'-monophosphate that has potent in vitro activity against HCV. |
|
T19862 |
Voxilaprevir
|
|
HCV Protease
|
|
Voxilaprevir is an inhibitor of hepatitis C virus (HCV) nonstructural (NS) protein 3/4A protease. |
|
T9331 |
Bemnifosbuvir hemisulfate
|
AT-527 |
HCV Protease
,
SARS-CoV
|
|
Bemnifosbuvir hemisulfate (AT-527) is a potent inhibitor of HCV virus replication. |
|
T25268L |
Coblopasvir dihydrochloride
|
Coblopasvir dihydrochloride(1312608-46-0 Free base) |
HCV Protease
|
|
Coblopasvir dihydrochloride can be used to study chronic HCV infection and is a pan-genotypic nonstructural protein 5A (NS5A) inhibitor. |
|
T3334 |
Velpatasvir
|
GS-5816 |
HCV Protease
,
SARS-CoV
|
|
Velpatasvir (GS-5816), also known as GS-5816, is a potent and selective Hepatitis C virus NS5A inhibitor. GS-5816 has demonstrated pan-genotypic activity and a high barrier to resistance in HCV replicon assays. GS-5816 d... |
